Uta Griesenbach

Professor of Molecular Medicine, National Heart and Lung Institute • Imperial College London

Uta is a Professor in Molecular Medicine  at Imperial College London, Ex-President of the British Society for Gene and Cell Therapy (2017 to 2021) and a Director (non-excecutive) of the Cell and Gene Therapy Catapult. Uta has over 20 years experience in developing advanced therapeutic medicines. Her reserach interests are related to the development of gene and cell therapy-based treatments for cystic fibrosis and other lung diseases. As part of her translational research, Uta has overseen vector and biomarker development, toxicology studies, as well as GMP vector manufacturing. Uta is Co-Investigator on several gene therapy trials. Uta is a Strategy Group Member of the UK Respiratory Gene Therapy Consortium. In addition, Uta is interested in teaching and work-force development. She is Deputy-director for post-graduate reserach at the National Heart and Lung Institute, Programme director for the MSc in Genes, Drugs and Stem cells-Novel Therapies at Imperial College and chairs the Pan-UK working group for ATMP workforce training.

Also speaking

Silvio Weber

Director Industrial Workflow Development, Cellular Therapy • Miltenyi Biotec

Sanjin Zvonic

Vice President Business Development and Practice Expert • Dark Horse Consulting

Sofia Hakansson Buch

Vice President for Cell Therapy CMC • Novo Nordisk

Event Info


Spotlight Roundtables

Take a look at the sample attendee list for Advanced Therapies Europe here.

Pub & Pints RSVP

Let us know you’re planning on attending.